Acer Therapeutics Announces ACER-801 IND Clearance For The Treatment Of Induced Vasomotor Symptoms
Acer Therapeutics Inc. (NASDAQ:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical
5 Stocks To Watch For November 22, 2021
Some of the stocks that may grab investor focus today are:
Wall Street expects Agilent Technologies, Inc. (NYSE: A) to report quarterly earnings at $1.03 per share on revenue of $1.45 billion after the closing bell. Agilent shares rose 0.4% to $164.90 in after-hours trading.
Acer Therapeutics Q3 EPS $(0.23) Up From $(0.51) YoY
Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.23) per share. This is a 54.9 percent increase over losses of $(0.51) per share from the same period last year.
Acer Therapeutics Receives Notice of Allowance Of Key U.S. Patent Application Covering ACER-001 Formulation
Acer Therapeutics Inc. (NASDAQ:ACER) ("Acer") and its collaboration partner, RELIEF THERAPEUTICS Holding SA ((SIX: RLF, OTCQB:RLFTF) ("Relief"), today announced that the U.S. Patent and Trademark
Mid-Afternoon Market Update: US Stocks Turn Positive; Hovnanian Enterprises Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.08% to 34,342.65 while the NASDAQ rose 0.38% to 14,489.14. The S&P also rose, gaining 0.19% to 4,353.99.
